-
This project was executed by Louis Pastor in the year 1885. The project is unique since this is the first vaccine invented for rabies. This project is temporary since it has a end date. The outcome of this project is to cure humans exposed to rabies virus. https://www.historyofvaccines.org/content/blog/world-rabies-day-rabies-vaccines
-
cholera vaccine project conducted by scientist and physician Jaime Ferran.Cholera vaccine is effective at preventing cholera. Cholera which is caused by bacteria called Vibrio cholerae. The project is unique first time developed the cholera vaccine.End date of the project is 1885 so the project is temporary. Outcome the vaccine protects against cholera.https://en.wikipedia.org/wiki/Cholera_vaccine
-
The project was executed by Almorth Wright. The project is unique since this is the first vaccine developed for typhoid fever. The project is temporary since the projects ends at 1896. The vaccine helps to protect against typhoid disease, an infections caused by typhoid bacteria. https://www.sciencephoto.com/media/93815/view/typhim-vi-typhoid-vaccine
-
it described by Charles Dotter in Interventional Radiology for improving blood flow. The first idea for modern medicine invented for curing peripheral arterial disease makes it unique. Balloon angioplasty treatment was successfully treated on a woman in the same year and that makes it a temporary project. Help to reduce the heart block and chance of heart attack is the outcome of this project. https://honestversion.com/wp-content/uploads/2019/02/Global-Angioplasty-Balloons-Market.jpg
-
The Rotarix vaccine introduced by an American pharmaceutical company called Wyeth. The first and only effective antivirus vaccination that makes this project unique. After the invention on1998 was licensed for use in the United States so the rotavirus vaccination was a temporary project. The outcome was it successfully disabled the live virus in the human body. (https://news.gsu.edu/files/2019/10/intestine.jpg)
-
The purpose of the project is providing protection against hepatitis A virus infections. it is an infection caused by virus which transmitted in unclean food and drink .The project is unique AVAXIM is best and effective immunization against infection caused by HAV in persons 12 years old.the project finished on April 6, 2001 ,so which is temporary and the outcome is the vaccine protect against hepatitis an infection.
https://pdf.hres.ca/dpd_pm/00032192.PDF -
The project executed by WHO and PATH funded by Bill and Melinda Gates Foundation. The project is unique as it is the first project done for finding the vaccine for group A meningococcal meningitis epidemic, the project is temporary as the project started on 2001 and ended on 2010.Development of vaccine and improved public health by the wide use is the outcome.
https://www.researchgate.net/figure/Endorsement-of-the-MVP-vaccine-development-consortiumSource-Meningitis-Vaccine-Project_fig2_283848171 -
The project was executed by Aaron Fenster, Western University, Canada.The project is unique as this were the only device to measure the fat concentration in liver tissue with indications for fatty liver disease using Radiographic fluoroscopy imaging.The project was temporary as it has proper start date 2018 and end date 2019.The outcome is to measure the fat content of liver tissue to assist in the diagnosis of fatty liver disease.
https://clinicaltrials.gov/ct2/show/NCT03757832 -
The kidney project is executing under University of California, San Francisco and Vanderbilt university. The project is unique because, this is the first project for the creation of bio-artificial kidney as a permanent solution for renal diseases. 1st phase started on 1998 and ended on 2010. 2nd phase started on 2014 and ended on 2019. The 3rd phase will end on 2020.So,it is temporary. The out come is the first human testing of bio-artificial kidney on 2020.
https://pharm.ucsf.edu/kidney/device -
created in the late 1980s by scientists working at SmithKline Beecham laboratories in Belgium.The vaccine was further developed through a collaboration between GSK .The project is unique as it is the world's first licensed malaria vaccine .Was temporary as it has proper start date(1984) and end date(2023).The outcome is first vaccine licensed for use against a human parasitic disease.
https://www.isglobal.org/en/-/rts-s-vaccine-immunology-study.